Andes Biotechnologies

Provider of nucleic acid-based drugs for the treatment of solid tumor cancers

placeSantiago, Santiago Metropolitan Region, Chile calendar_todayFounded 2008 groups3 employees language andesbio.com

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 1,015 times.

YearFilings
20121
20143
20154
20164
20174
20182
20201
20211
20221

Investor mix

3 investors on record.

Investor typeCountShare
Other / undisclosed3100%
Coming soon